After adjustment for age and gender (Model 1) and for age, gender, glucose, triglycerides, apoA1, apoB100, and AST (Model 2), the associations between FABP4 and liver steatosis were significant in all the studied groups, including obese patients. The gene discussed is APOB; the disease is fatty liver disease.